Market Cap 76.84B
Revenue (ttm) 177.01B
Net Income (ttm) 5.98B
EPS (ttm) N/A
PE Ratio 11.50
Forward PE 13.57
Profit Margin 3.38%
Debt to Equity Ratio 0.72
Volume 851,879
Avg Vol 1,626,284
Day's Range N/A - N/A
Shares Out 222.24M
Stochastic %K 37%
Beta 0.51
Analysts Strong Sell
Price Target $388.26

Company Profile

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. It operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. The company offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products...

Industry: Healthcare Plans
Sector: Healthcare
Phone: 833 401 1577
Address:
220 Virginia Avenue, Indianapolis, United States
SyriaHuanb
SyriaHuanb Feb. 4 at 6:43 PM
$GORO $ELV Dispersed chips
0 · Reply
Estimize
Estimize Feb. 4 at 2:46 PM
Wall St is expecting 10.57 EPS for $ELV Q1 [Reporting 04/22 BMO] http://www.estimize.com/intro/elv?chart=historical&metric_name=eps&utm_con
0 · Reply
CrestMarkets
CrestMarkets Feb. 4 at 11:27 AM
$ELV is the parent of Elevance Health, a major Blue Cross Blue Shield licensee; its health services platform is a differentiator.
0 · Reply
EvBullforever13
EvBullforever13 Feb. 4 at 3:25 AM
$OSCR this is one you don’t want to miss… $UNH $CNC $ELV $MOH
1 · Reply
Bazzzigar
Bazzzigar Feb. 4 at 12:46 AM
$ELV HUM
0 · Reply
Lucid100plus
Lucid100plus Feb. 3 at 6:50 PM
$ELV $339.99 … $319.99 … $289.99 … $249.99
0 · Reply
erevnon
erevnon Feb. 2 at 6:22 PM
JP Morgan maintains Elevance Health $ELV at Overweight and raises the price target from $394 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
EvBullforever13
EvBullforever13 Jan. 30 at 2:31 AM
$OSCR easy buy…. $UNH $HIMS $CNC $ELV
0 · Reply
Bazzzigar
Bazzzigar Jan. 29 at 7:49 PM
$ELV HUM UNH
0 · Reply
IN0V8
IN0V8 Jan. 29 at 7:34 PM
$ELV Buy Deutsche Bank raises target price to $332 from $320 Leerink Partners raises target price to $357 from $350 UBS cuts target price to $400 from $425
0 · Reply
Latest News on ELV
Elevance Health, Inc. (ELV) Q4 2025 Earnings Call Transcript

Jan 28, 2026, 1:02 PM EST - 7 days ago

Elevance Health, Inc. (ELV) Q4 2025 Earnings Call Transcript


Elevance Health Reflects On The Changed Role of Health Plans

Dec 12, 2025, 2:00 PM EST - 7 weeks ago

Elevance Health Reflects On The Changed Role of Health Plans


Artisan Select Equity Fund Q3 2025 Portfolio Review

Nov 27, 2025, 5:04 AM EST - 2 months ago

Artisan Select Equity Fund Q3 2025 Portfolio Review

ARMK GOOG HSIC LRCX


Retirement: 2 Healthcare Giants To Buy At Discounted Prices

Nov 21, 2025, 8:00 AM EST - 2 months ago

Retirement: 2 Healthcare Giants To Buy At Discounted Prices

MRK


First Eagle U.S. Fund Q3 2025 Portfolio Review

Nov 9, 2025, 2:01 PM EST - 3 months ago

First Eagle U.S. Fund Q3 2025 Portfolio Review

CMCSA CRM GOOG ORCL PM GOOGL


Columbia Balanced Fund Q3 2025 Portfolio Update

Nov 4, 2025, 2:30 AM EST - 3 months ago

Columbia Balanced Fund Q3 2025 Portfolio Update

EA EBAY INTU TEL VRTX


Artisan Global Value Fund Q3 2025 Portfolio Update

Oct 30, 2025, 12:30 AM EDT - 3 months ago

Artisan Global Value Fund Q3 2025 Portfolio Update

BK GOOG GOOGL PGR


Elevance Health: Q3 Figures Underscore Slow But Steady Recovery

Oct 24, 2025, 3:29 AM EDT - 3 months ago

Elevance Health: Q3 Figures Underscore Slow But Steady Recovery


Elevance: Checking Out The Q3 Report

Oct 22, 2025, 7:12 AM EDT - 3 months ago

Elevance: Checking Out The Q3 Report


Elevance Health, Inc. (ELV) Q3 2025 Earnings Call Transcript

Oct 21, 2025, 11:54 AM EDT - 3 months ago

Elevance Health, Inc. (ELV) Q3 2025 Earnings Call Transcript


Elevance Health Quarterly Profit Climbs as Memberships Slip

Oct 21, 2025, 7:27 AM EDT - 3 months ago

Elevance Health Quarterly Profit Climbs as Memberships Slip


Elevance Health Reports Third Quarter 2025 Results

Oct 21, 2025, 6:00 AM EDT - 3 months ago

Elevance Health Reports Third Quarter 2025 Results


Managed Care Insurers Trading Down Ahead Of Earnings Season

Oct 18, 2025, 5:30 AM EDT - 3 months ago

Managed Care Insurers Trading Down Ahead Of Earnings Season

CI CNC HUM UNH


SyriaHuanb
SyriaHuanb Feb. 4 at 6:43 PM
$GORO $ELV Dispersed chips
0 · Reply
Estimize
Estimize Feb. 4 at 2:46 PM
Wall St is expecting 10.57 EPS for $ELV Q1 [Reporting 04/22 BMO] http://www.estimize.com/intro/elv?chart=historical&metric_name=eps&utm_con
0 · Reply
CrestMarkets
CrestMarkets Feb. 4 at 11:27 AM
$ELV is the parent of Elevance Health, a major Blue Cross Blue Shield licensee; its health services platform is a differentiator.
0 · Reply
EvBullforever13
EvBullforever13 Feb. 4 at 3:25 AM
$OSCR this is one you don’t want to miss… $UNH $CNC $ELV $MOH
1 · Reply
Bazzzigar
Bazzzigar Feb. 4 at 12:46 AM
$ELV HUM
0 · Reply
Lucid100plus
Lucid100plus Feb. 3 at 6:50 PM
$ELV $339.99 … $319.99 … $289.99 … $249.99
0 · Reply
erevnon
erevnon Feb. 2 at 6:22 PM
JP Morgan maintains Elevance Health $ELV at Overweight and raises the price target from $394 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
EvBullforever13
EvBullforever13 Jan. 30 at 2:31 AM
$OSCR easy buy…. $UNH $HIMS $CNC $ELV
0 · Reply
Bazzzigar
Bazzzigar Jan. 29 at 7:49 PM
$ELV HUM UNH
0 · Reply
IN0V8
IN0V8 Jan. 29 at 7:34 PM
$ELV Buy Deutsche Bank raises target price to $332 from $320 Leerink Partners raises target price to $357 from $350 UBS cuts target price to $400 from $425
0 · Reply
phantomtrader75
phantomtrader75 Jan. 29 at 5:20 AM
$ELV sadly this is going to refill that gap from today. $280 incoming.
0 · Reply
Estimize
Estimize Jan. 28 at 11:04 PM
$ELV reported 3.33 EPS and 49,311 revenue for Q4. http://www.estimize.com/intro/elv?chart=historical&metric_name=eps&utm_content=ELV&utm_me
0 · Reply
FreeMoneyandFed
FreeMoneyandFed Jan. 28 at 9:43 PM
$HUM only silver lining for this is relatively low float of 120M and daily avg volume of less than 1M. which makes it easy to manipulate by algos Last two days total volume 20M. Before that around 800k Depends on when the inst algos decide to flip to buying.. On the other hand $ELV $UNH Have recoverd a bit . When only one player is considered the bad apple, it is difficult to reverse. Like someone else mentioned , what is surprising is management keeping quiet while the stock bleeds to 10 years low ! At least for the sake of ESOP they should say something. $SPY
1 · Reply
RunnerSignals
RunnerSignals Jan. 28 at 9:26 PM
top stock market warriors $NAMM $VG $ELV $ALKT $OPTX Started down ended up
0 · Reply
ZacksResearch
ZacksResearch Jan. 28 at 5:52 PM
Elevance Health just beat Q4 earnings — but the details matter here 💥📊 $ELV topped Q4 EPS estimates as increasing premiums and surging Carelon revenues drove results, even as medical membership slipped and expenses climbed. Get the full breakdown behind the beat 👉 https://www.zacks.com/stock/news/2824622/elevance-health-q4-earnings-beat-estimates-on-increasing-premiums?cid=sm-stocktwits-2-2824622-teaser-30773&ADID=SYND_STOCKTWITS_TWEET_2_2824622_TEASER_30773
0 · Reply
cubie
cubie Jan. 28 at 5:11 PM
$HUM Sure did ribbey😅. Humana and cnc didnt dead cat bounce today like $UNH $CVS $ELV moh
0 · Reply
Hrumph63
Hrumph63 Jan. 28 at 4:58 PM
$ELV great resilience!!!
0 · Reply
StockKiiNG
StockKiiNG Jan. 28 at 4:53 PM
$CVS $ELV $HUM $UNH maybe we will see a buyout by $CVS
0 · Reply
ZacksResearch
ZacksResearch Jan. 28 at 4:52 PM
$ELV Q4 earnings beat, but next year's outlook is gloomy! ⚠️ Despite a 7.3% EPS beat and robust premium growth, ELV's 2026 outlook points to a 15.8% EPS decline and lower operating revenues. Medical membership is also forecasted to drop. Understand the risks before investing in ELV 👉 https://www.zacks.com/stock/news/2824622/elevance-health-q4-earnings-beat-estimates-on-increasing-premiums?cid=sm-stocktwits-2-2824622-body-30740&ADID=SYND_STOCKTWITS_TWEET_2_2824622_BODY_30740
0 · Reply
JohnAnthony_
JohnAnthony_ Jan. 28 at 4:41 PM
$ELV why we pumping here? Bueller Bueller
0 · Reply
BioTechHealthX
BioTechHealthX Jan. 28 at 4:37 PM
$ELV Elevance Health Inc. (NYSE: ELV) is deeply embedded in U.S. healthcare, from Medicaid to Medicare Advantage. This article explores why ELV stock remains a sleeper giant in the market. https://biotechhealthx.com/biotech-news/elevance-health-elv-touches-millions-every-day-yet-it-rarely-makes-headlines/
0 · Reply
312bunny
312bunny Jan. 28 at 4:35 PM
$ELV start here kiddo https://www.milliman.com/en/insight/analyzing-aca-market-landscape-2025-rate-submissions Learn how issuers work. Learn how ACA subsidies work.
1 · Reply